发明公开
EP3199157A1 DYSLIPIDEMIA THERAPEUTIC AGENT 审中-公开
DYSLIPIDEMIA治疗剂

DYSLIPIDEMIA THERAPEUTIC AGENT
摘要:
This invention provides a combination-drug composition and a combination use of pharmaceuticals for preventing and/or treating dyslipidemic conditions such as hyper-LDL cholesterolemia in mammals, including humans.
This invention pertains to a drug composition for preventing and/or treating dyslipidemia and the like, said drug composition comprising the following: (R)-2-[3-[[N-(benzoxazole-2-yl)-N-3-(4-methoxyphenoxy)propy 1]aminomethyl]phenoxyl butyric acid, a salt thereof, or a solvate of either; and (S)-trans-{4-[({2-[({1-[3,5-bis(trifluoromethyl)phenyl]ethy 1}{5-[2-(methylsulfonyl)ethoxy]pyrimidine-2-yl}amino)methyl ]-4-(trifluoromethyl)phenyl}(ethyl)amino)methyl]cyclohexyl} butyric acid, a salt thereof, or a solvate of either.
信息查询
0/0